AI Article Synopsis
- The study explores how people's ethical decisions in sacrifice dilemmas (sacrificing one to save many) relate to two different ethical frameworks: deontological ethics, which opposes causing harm, and utilitarian ethics, which focuses on maximizing overall good.
- Researchers conducted four studies with a total of 1,116 participants, manipulating the perceived moral character of the sacrificial target to see how this affected ethical decision-making.
- Results indicated that participants were less likely to reject harm (consistent with utilitarianism) when the target was perceived as guilty rather than innocent, while general beliefs about justice and fair treatment influenced both ethical perspectives, though these effects were diminished when psychopathy traits were taken into account.
Article Abstract
Sacrificing a target to save a group violates deontological ethics against harm but upholds utilitarian ethics to maximize outcomes. Although theorists examine many factors that influence dilemma decisions, we examined justice concerns: We manipulated the moral character of sacrificial targets, then measured participants' dilemma responses and just world beliefs. Across four studies (=1116), participants considering guilty versus innocent targets scored lower on harm-rejection (deontological) responding, but not outcome-maximizing (utilitarian) responding assessed via process dissociation. Just world beliefs (both personal and general) predicted lower utilitarian and somewhat lower deontological responding, but these effects disappeared when accounting for shared variance with psychopathy. Results suggest that dilemma decisions partly reflect the moral status of sacrificial targets and concerns about the fairness implications of sacrificing innocent targets to save innocent groups.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/01461672241287815 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Machine Learning and Computed Tomography Radiomics to Predict Disease Progression to Upfront Pembrolizumab Monotherapy in Advanced Non-Small-Cell Lung Cancer: A Pilot Study.
Cancers (Basel)
December 2024
BC Cancer, Vancouver Center, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
Background/objectives: Pembrolizumab monotherapy is approved in Canada for first-line treatment of advanced NSCLC with PD-L1 ≥ 50% and no EGFR/ALK aberrations. However, approximately 55% of these patients do not respond to pembrolizumab, underscoring the need for the early intervention of non-responders to optimize treatment strategies. Distinguishing the 55% sub-cohort prior to treatment is a real-world dilemma.
View Article and Find Full Text PDFTherapeutic Dilemmas Arising From a Serpentine Thrombus Across a Patent Foramen Ovale in a Patient With Dilated Cardiomyopathy.
Cureus
December 2024
Cardiology/Internal Medicine, Luton and Dunstable University Hospital, Luton, GBR.
A thrombus straddling a patent foramen ovale (TSPFO) is a rare condition that presents significant health risks, including stroke or myocardial infarction, and can be life-threatening if not promptly addressed. We report the case of a 42-year-old female with morbid obesity who presented with sudden shortness of breath due to a bilateral pulmonary embolism. Imaging revealed a thrombus extending from the right atrium to the left atrium through the patent foramen ovale (PFO).
View Article and Find Full Text PDFTruth-telling for terminally ill patients is a challenging ethical and social issue for Chinese health care professionals. However, despite the existence of ethical and moral standards for nurses, they frequently encounter moral dilemmas when making decisions about truth-telling to patients with end-stage diseases in China. This article aims to provide ethical strategies for clinical nurses in China regarding truth-telling decisions for terminally ill patients on the basis of their individual autonomy.
View Article and Find Full Text PDFComplete Heart Block in a Patient Declining Pacemaker Implantation: A Discussion on Patient-Centered Care and Shared Decision-Making.
Cureus
December 2024
Cardiology, Wright State University Boonshoft School of Medicine, Dayton, USA.
Permanent pacemaker (PPM) implantation is the standard of care in patients with complete heart block (CHB) and second-degree type II atrioventricular (AV) block irrespective of patient symptoms when the conduction abnormality is irreversible. CHB generally constitutes a medical emergency that can be fatal if not urgently treated. This is in contrast to first-degree AV block and second-degree type I AV block, which require PPM implantation only in very special circumstances.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!